Back to News
Market Impact: 0.4

Hawkins (HWKN) Q1 Earnings and Revenues Top Estimates

HWKNSPYCE
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst EstimatesAnalyst Insights
Hawkins (HWKN) Q1 Earnings and Revenues Top Estimates

Hawkins (HWKN) reported strong Q1 results, with adjusted earnings of $1.40 per share, exceeding the Zacks Consensus Estimate of $1.33, and revenues of $293.27 million, surpassing expectations by 4.38% and growing year-over-year. Despite the company's shares significantly outperforming the S&P 500 year-to-date with a 30.9% gain, the stock holds a Zacks Rank #3 (Hold), suggesting an expected performance in line with the broader market, with future stock movement largely dependent on management's commentary and the company's position within the lower-ranked Chemical - Specialty industry.

Analysis

Hawkins (HWKN) reported a strong first quarter, exceeding consensus estimates on both revenue and earnings. The company posted quarterly revenues of $293.27 million, a 4.38% beat and a notable increase from the $255.88 million reported in the year-ago period. Earnings per share came in at $1.40, surpassing the Zacks Consensus Estimate of $1.33 by 5.26%, although this represents a slight dip from the $1.38 EPS a year ago. This performance continues a trend of positive revenue surprises, with the company topping revenue estimates three times in the last four quarters. Despite this operational strength and significant stock outperformance year-to-date—a 30.9% gain versus the S&P 500's 8.3%—several factors suggest a more cautious outlook. The stock carries a Zacks Rank #3 (Hold), indicating an expectation of in-line market performance, potentially tempered by its placement in the Chemical - Specialty industry, which ranks in the bottom 32% of all Zacks industries. The negative outlook for peer Celanese (CE), which anticipates a 42% year-over-year earnings decline, underscores potential sector-wide headwinds that could challenge HWKN's momentum.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo